Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits.

< BACK TO ARCHIVE


2022 Sep 15


Magn Reson Med


http://www.ncbi.nlm.nih.gov/pubmed/36111354?dopt=Abstract

Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits.

Authors

Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits.
Huang X-X, Jiang R-H, Xu X-Q, Wang W, Sun Y-Q, Li L, Shi H-B, Liu S
Magn Reson Med. 2022 Sep 15.
PMID: 36111354.

Abstract

To investigate the effects of gadolinium (Gd) retention of macrocyclic (gadobutrol) or linear (gadopentetate) Gd-based contrast agents (GBCAs) on neuron loss, neurological deficits, and sensory behavior in mice with or without stroke.
Read This Paper